(Q38416814)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581902%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581902%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581902%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

J-L Faillie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581902%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

V Patenaude

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581902%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

P Ernst

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581902%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

L Azoulay

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581902%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

3 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581902%20AND%20SRC:MED&resulttype=core&format=json

Diabetes, Obesity and Metabolism

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581902%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581902%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581902%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

379-385

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581902%20AND%20SRC:MED&resulttype=core&format=json

Biological actions and therapeutic potential of the glucagon-like peptides

27 February 2020

cites work

1 reference

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

21 January 2018

1 reference

Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types

21 January 2018

1 reference

Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses

21 January 2018

1 reference

Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo

21 January 2018

1 reference

Dipeptydil peptidase-4 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis

21 January 2018

1 reference

Use of dipeptidyl peptidase-4 inhibitors and the reporting of infections: a disproportionality analysis in the World Health Organization VigiBase

21 January 2018

1 reference

New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records

21 January 2018

1 reference

Clinical practice. Community-acquired pneumonia

21 January 2018

1 reference

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

21 January 2018

1 reference

The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies

21 January 2018

1 reference

Use of the UK General Practice Research Database for pharmacoepidemiology

21 January 2018

1 reference

Validation and validity of diagnoses in the General Practice Research Database: a systematic review

21 January 2018

1 reference

Application of the missing-indicator method in matched case-control studies with incomplete data

21 January 2018

1 reference

Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis

21 January 2018

1 reference

Dipeptidyl peptidases and related proteins: multifaceted markers and therapeutic targets.

21 January 2018

1 reference

Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes.

21 January 2018

1 reference

Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition

21 January 2018

1 reference

Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database

21 January 2018

1 reference

Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study.

21 January 2018

1 reference

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study.

21 January 2018

1 reference

Safety and tolerability of sitagliptin in type 2 diabetes: pooled analysis of 25 clinical studies

21 January 2018

1 reference

Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis

21 January 2018

1 reference

Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis

21 January 2018

1 reference

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

21 January 2018

1 reference

Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus

21 January 2018

1 reference

Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus

21 January 2018

1 reference

Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002.

21 January 2018

1 reference

Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DOM.12431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581902%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference